Corvus Pharmaceuticals (CRVS)
(Delayed Data from NSDQ)
$2.17 USD
-0.06 (-2.69%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $2.18 +0.01 (0.46%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Earnings News For CRVS
-
Corvus: Q1 Earnings Snapshot
-
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results
-
Corvus: Q4 Earnings Snapshot
-
Corvus: Q4 Earnings Snapshot
-
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Corvus: Q3 Earnings Snapshot
-
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results
-
Corvus: Q2 Earnings Snapshot
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
-
Corvus: Q1 Earnings Snapshot
-
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
-
Corvus: Q4 Earnings Snapshot
-
Corvus: Q4 Earnings Snapshot
-
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
-
Corvus: Q3 Earnings Snapshot
-
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
-
Corvus: Q2 Earnings Snapshot
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results